Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome ; day:30 ; month:10 ; year:2020 ; pages:1-10
Journal of neurology ; (30.10.2020), 1-10
- Urheber
-
Tjensvoll, Anne B.
Lauvsnes, Maria B.
Zetterberg, Henrik
Kvaløy, Jan T.
Kvivik, Ingeborg
Maroni, Stian S.
Greve, Ole J.
Beyer, Mona K.
Hirohata, Shunsei
Putterman, Chaim
Alves, Guido
Harboe, Erna
Blennow, Kaj
Gøransson, Lasse G.
Omdal, Roald
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-10290-y
- URN
-
urn:nbn:de:101:1-2020121322133800136271
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tjensvoll, Anne B.
- Lauvsnes, Maria B.
- Zetterberg, Henrik
- Kvaløy, Jan T.
- Kvivik, Ingeborg
- Maroni, Stian S.
- Greve, Ole J.
- Beyer, Mona K.
- Hirohata, Shunsei
- Putterman, Chaim
- Alves, Guido
- Harboe, Erna
- Blennow, Kaj
- Gøransson, Lasse G.
- Omdal, Roald
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study